Table 3.
The table shows the specific metabolites that significantly changed in the related cohorts compared to the other ARDS and control cohorts
| Specific to C19/A |
Specific to H1N1/A |
Specific to PNA/A |
|
|---|---|---|---|
| C12 DC | ** | ||
| C14:2 OH | ** | ||
| C16:1 | ** | ||
| C3OH | ** | ||
| C9 | ** | ||
| Fumaric acid | ** | ||
| Indole acetic acid | * | ||
| Lactic acid | * | ||
| LysoPC a C18:1 | ** | ||
| PC ae C36:0 | * | ||
| Pyruvic acid | ** | ||
| SM (OH) C24:1 | * | ||
| SM C16:1 | * | ||
| SM(OH) C22:1 | ** | ||
| SM(OH) C24:1 | * | ||
| α-Aminoadipic acid | ** |
*Metabolite significantly changed (p-value < 0.05) only in the cohort compared to other ARDS cohorts. **Metabolite significantly changed (p-value < 0.05) in the cohort compared to other ARDS cohorts and the control cohort